Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Cash from Investing Activities (2018 - 2026)

Equillium (EQ) posted quarterly Cash from Investing Activities of -$3000.0 for Q1 2026, down 100.07% year-over-year from $4.5 million in Q1 2025, and up 90.62% quarter-over-quarter from -$32000.0 in Q4 2025.

Analysis

Equillium (EQ) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Equillium (EQ) has reported Cash from Investing Activities for 9 consecutive years, with -$3000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 100.07% year-over-year to -$3000.0; the TTM figure through Mar 2026 stood at -$35000.0 (down 100.17% YoY), while the FY2025 annual figure was $4.5 million, down 67.68% from the prior year.
  • Cash from Investing Activities rose to -$3000.0 in Q1 2026 per EQ's latest filing, from -$32000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $15.0 million in Q3 2022 and bottomed at -$25.2 million in Q1 2023.
  • Historically, Cash from Investing Activities has averaged $2.1 million across 5 years, with a median of $4.5 million in 2025.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 346.6% — and 2025, when it surged 258.81%.
  • Equillium's Cash from Investing Activities stood at $7.0 million in 2022, then plunged by 179.76% to -$5.6 million in 2023, then jumped by 207.73% to $6.0 million in 2024, then tumbled by 100.53% to -$32000.0 in 2025, then surged by 90.62% to -$3000.0 in 2026.
  • Business Quant data shows EQ's Cash from Investing Activities at -$3000.0 in Q1 2026, -$32000.0 in Q4 2025, and $4.5 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Equillium 249.33 Mn 249.33 Mn - -71,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -71,000.00
Mar 31, 2026 -3,000.00
Dec 31, 2025 -32,000.00
Mar 31, 2025 4.50 Mn
Dec 31, 2024 6.00 Mn
Sep 30, 2024 12.00 Mn
Jun 30, 2024 -1.35 Mn
Mar 31, 2024 -2.83 Mn
Dec 31, 2023 -5.57 Mn
Sep 30, 2023 10.99 Mn
Jun 30, 2023 15.00 Mn
Mar 31, 2023 -25.18 Mn
Dec 31, 2022 6.98 Mn
Sep 30, 2022 15.00 Mn
Jun 30, 2022 8.69 Mn
Mar 31, 2022 -11.99 Mn
Dec 31, 2021 -16.89 Mn
Sep 30, 2021 10.47 Mn
Jun 30, 2021 28.97 Mn
Mar 31, 2021 4.86 Mn